Union Savings Bank Sells 180 Shares of UnitedHealth Group Incorporated $UNH

Union Savings Bank decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 27.8% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 467 shares of the healthcare conglomerate’s stock after selling 180 shares during the period. Union Savings Bank’s holdings in UnitedHealth Group were worth $146,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Brighton Jones LLC lifted its position in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC raised its position in shares of UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after acquiring an additional 2,324 shares in the last quarter. Markel Group Inc. grew its stake in UnitedHealth Group by 4.9% in the first quarter. Markel Group Inc. now owns 28,014 shares of the healthcare conglomerate’s stock valued at $14,672,000 after purchasing an additional 1,300 shares during the last quarter. Independent Wealth Network Inc. grew its position in shares of UnitedHealth Group by 8.4% in the 1st quarter. Independent Wealth Network Inc. now owns 503 shares of the healthcare conglomerate’s stock worth $263,000 after buying an additional 39 shares during the last quarter. Finally, Jennison Associates LLC boosted its stake in UnitedHealth Group by 105.4% in the first quarter. Jennison Associates LLC now owns 502,076 shares of the healthcare conglomerate’s stock valued at $262,962,000 after acquiring an additional 257,599 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 3.3%

Shares of UNH opened at $321.44 on Friday. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The firm has a market capitalization of $291.17 billion, a P/E ratio of 16.78, a P/E/G ratio of 2.28 and a beta of 0.47. The firm has a 50-day moving average price of $347.65 and a 200 day moving average price of $320.06. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $622.83.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. During the same quarter last year, the firm earned $7.15 EPS. The business’s revenue was up 12.2% compared to the same quarter last year. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s dividend payout ratio is presently 46.14%.

Analyst Ratings Changes

Several brokerages recently weighed in on UNH. TD Cowen boosted their target price on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research note on Thursday, October 30th. UBS Group raised their price target on shares of UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a report on Wednesday, October 29th. Deutsche Bank Aktiengesellschaft lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 target price for the company. in a research note on Wednesday, October 29th. Morgan Stanley lifted their target price on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. Finally, Oppenheimer dropped their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Eighteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.